133
Views
3
CrossRef citations to date
0
Altmetric
Articles

Registered blindness in Kuwait – 15 years of dynamic changes

, &
Pages 75-83 | Received 19 Jul 2017, Accepted 06 Sep 2018, Published online: 04 Oct 2018

References

  • Al-Merjan JI, Pandova MG, Al-Ghanim M, et al. Registered blindness and low vision in Kuwait. Ophthalmic Epidemiol. 2005;12(4):251–257.
  • Sadeq N., Zamzam A.,M. Pandova Kuwait National Eye Study. Assessment of prevalence and etiology of blindness and visual impairment in Kuwait. 2008.
  • Sadeq Nadia, Pandova Maya. Blindness and Low Vision Among Kuwaiti Population Over the Age of 40, World Congress of Ophthalmology Abu Dhabi 2012, Abstract  Book, FP-EPI-MO 384 (6).
  • Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010.Br J Ophthalmol. 2012;96(5):614–618.
  • Stevens GA, White RA, Flaxman SR, et al. Vision Loss Expert Group .Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013;120(12):2377–2384.
  • Khairallah M, Kahloun R, Flaxman SR, et al. Vision Loss Expert Group.Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010. Br J Ophthalmol. 2014;98(5):605–11.
  • Wolfram C, Pfeiffer N. Blindness and low vision in Germany 1993-2009. Ophthalmic Epidemiol. 2012;19(1):3–7.
  • Skaat A, Chetrit A, Belkin M, Kinori M, et al. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol. 2012;153(2):214-221.
  • Cheung N, Wong TY. Changing trends of blindness: the initial harvest from translational public health and clinical research in ophthalmology. Am J Ophthalmol. 2012;153(2):193–5.
  • Yong VK, Morgan WH, Cooper RL et al. Trends in registered blindness and its causes over 19 years in Western Australia. OphthalmicEpidemiol. 2006 ;13(1):35–42.
  • Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England &WalesBMC Public Health. 2006;6:58.
  • Resnikoff S, Keys TU. Future trends in global blindness. Indian J Ophthalmol. 2012;60(5):387–95.
  • Mezer E, Chetrit A, Kalter-Leibovici O, et al. Trends in the incidence and causes of severe visual impairment and blindness in children from Israel. J AAPOS. 2015;19(3):260–5.e1.
  • Bourkiza R, Subash M, Qatarneh D et al. Barriers to sight impairment certification in the UK: the example of a population with diabetes in East London. BMC Ophthalmol. 2014;14:99.
  • Quartilho A, Simkiss P, Zekite A et al. Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013. Eye (Lond). 2016;30(4):602–7.
  • Liew G, Michaelides M, Bunce C .A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014 12;4(2):e004015.
  • Tadmouri GO, Nair P, Obeid T, et al. Consanguinity and reproductive health among Arabs. Reprod Health. 2009 8;6:17. Institute www.dasmaninstitute.org
  • Alsmadi O, Thareja G, Alkayal F, et al. Genetic Substructure of Kuwaiti Population Reveals Migration History. PLoS ONE. 2013;8(9):e74913. Retrieved from www.idf.org/membership/mena/kuwait
  • Cruciani F, Amore F, Albanese G et al. Investigation about causes of blindness and low vision among members of Blind and Visually Impaired Italian Union (UICI). Clin Ter. 2011;162(2):e35–42. http://Kuwait<www.diabetes.org.kw›diabetes
  • Mokdad AH, Jaber S, Aziz MI, et al. The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014;383(9914):309–320.
  • Al Khalaf MM, Eid MM, Najjar HA, et al. Screening for diabetes in Kuwait and evaluation of risk scores. EastMediterr Health J. 2010;16(7):725–731.
  • Channanath AM, Farran B, Behbehani K, et al. State of diabetes, hypertension, and comorbidity in Kuwait: showcasing the trends as seen in native versus expatriate populations. Diabetes Care. 2013;36(6):e75.
  • Flaxman SR, Bourne RRA, Resnikoff S, et al. Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.Lancet Glob Health. 2017 10. pii: S2214–109X(17)30393-5. Retrieved from http://www.idf.org/diabetesatlas
  • Tham YC, Li X, Wong TY, Quigley HA, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 ;121(11):2081–2090.
  • Kapetanakis VV, Chan MP, Foster PJ, et al. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016;100(1):86–93.
  • GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191.
  • Al-Shaaln FF, Bakrman MA, Ibrahim AM et al. Prevalence and causes of visual impairment among Saudi adults attending primary health care centers in northern Saudi Arabia. Ann Saudi Med. 2011;31(5):473–480.
  • Rabiu MM, Al Bdour MD, Abu Ameerh MA et al. Prevalence of blindness and diabetic retinopathy in northern Jordan. Eur J Ophthalmol. 2015;25(4):320–327.
  • Finger RP, Fimmers R, Holz FG, Scholl HP. Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci. 2011;52(7):4381–4389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.